As of June 17, 2025, Xtant Medical Holdings Inc (XTNT) reports a ROA (Return on Assets) of -17.53%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Xtant Medical Holdings Inc's ROA (Return on Assets)
Over recent years, Xtant Medical Holdings Inc's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2024-12-31 | -17.53% |
| 2023-12-31 | 0.71% |
| 2022-12-31 | -14.09% |
| 2021-12-31 | -8.87% |
| 2020-12-31 | -16.94% |
This slight downward trend highlights how Xtant Medical Holdings Inc manages its efficiency in using assets to generate earnings over time.
Comparing Xtant Medical Holdings Inc's ROA (Return on Assets) to Peers
To better understand Xtant Medical Holdings Inc's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| Xtant Medical Holdings Inc (XTNT) | -17.53% |
| Antares Pharma Inc (ATRS) | 17.98% |
| Utah Medical Products Inc (UTMD) | 11.32% |
| E Med Future Inc (EMDF) | - |
| OraSure Technologies Inc (OSUR) | -4.07% |
| YBCC Inc (YBAO) | -4.09% |
Compared to its competitors, Xtant Medical Holdings Inc's ROA (Return on Assets) is about average compared to peers, indicating typical asset efficiency for the industry.